SCPH — Scpharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- $168.01m
- $130.81m
- $13.59m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 72.6 | 105 | 75.3 | 118 | 76 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.31 | — | — | — | 4.49 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 75.6 | 108 | 78.3 | 123 | 92.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.31 | 0.908 | 0.479 | 0.62 | 1.46 |
Other Long Term Assets | |||||
Total Assets | 77.3 | 109 | 79 | 124 | 94.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.24 | 9.32 | 14.8 | 7.42 | 13.1 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 25.9 | 26.9 | 22.6 | 51.8 | 57.3 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 51.4 | 82.2 | 56.5 | 72.4 | 37.2 |
Total Liabilities & Shareholders' Equity | 77.3 | 109 | 79 | 124 | 94.5 |
Total Common Shares Outstanding |